KLOW peptide's stability half-life in solution is approximately 14 days at 4C, meaning potency drops by 50% every two weeks even under ideal refrigeration
To treat breast cancer with antiangiogenesis, berberine inhibits the primary angiogenic factors, which could lead to an excitingly low toxicity and relatively active antitumour drug (95)
Comment CURCUMIN or send a message, and we can explore how to optimize your next formulation with clinically relevant Curcumin + Piperine synergy.#Health, #Wellness, #Nutrition, #Supplements, #NaturalHealth, #Curcumin, #Piperine, #Bioavailability, #AntiInflammatory, #HerbalFormulation, #FunctionalFoods, #TurmericSupplements, #CleanLabel, #PlantBased, #FormulationScience, #Nutraceuticals, #BioactiveCompounds, #InnovationInHealth, #CurcuminSynergy, #SupplementScience To view or add a comment, sign in 8,274 followers
Novel glutathione-dependent thiopurine prodrugs: evidence for enhanced cytotoxicity in tumor cells and for decreased bone marrow toxicity in mice
